A recent television advertisement for a topical analgesic cream is reviewed with an analysis and discussion of the claims made in the commercial concerning the mode of action and the effectiveness of the product. The claims, although based on fact, may be considered to be speculative. Advertisements of this type prove counterproductive to the educational efforts of health educators.
Get full access to this article
View all access options for this article.
References
1.
PayneD. E., The Relationship Between Television Advertising and Drug Abuse Among Youth: Fancy and Fact, Journal of Drug Education, 6:3, pp. 215–220, 1976.
2.
SkierkowskiP.BurdockN., External Analgesic Products, Handbook of Non-Prescription Drugs, Sixth Edition, American Pharmaceutical Association, pp. 353–360, 1979.
3.
Federal Register, 44:234, pp. 69766–69866, 1979.
4.
FinglE.WoodburyD. M., Analgesic-Antipyretics, Anti-Inflammatory Agents, GoodmanL. S.GilmanA. (eds.), The Pharmacological Basis of Therapeutics, Fifth Edition, pp. 325–358, 1975.
5.
FerreiraS. H.VaneJ. R., New Aspects of the Mode of Action of Nonsteriod Anti-Inflammatory Drugs, Annual Review of Pharmacology, 14, pp. 57–73, 1974.
6.
BoardmanP. L.HartF. D., Clinical Measurement of the Anti-Inflammatory Effects of Salicylates in Rheumatoid Arthritis, British Medical Journal, 4, pp. 264–268, 1967.
7.
DoedharS. D.DictaW. C.HodgkinsonR.BuchananW. N., Measurement of Clinical Response to Anti-Inflammatory Drug Therapy in Rheumatoid Arthritis, Quarterly Medical Journal, 42, pp. 387–401, 1973.
8.
MultzC. V.BernhardG. C.BlechmanW. C.ZaneS.RestifoR. A.VaradyJ. C., A Comparison of Intermediate-Dose Aspirin and Placebo in Rheumatoid Arthritis, Clinical Pharmacology and Therapeutics, 15, pp. 310–315, 1974.
9.
MorganE.KellyP.NiesK.PorterW. W.PaulusH. E., Tinnitus as an Indication of Therapeutic Serum Salicylate Levels, Journals of the American Medical Association, 226, pp. 142–143, 1973.
10.
Von WeissJ. F.LeverW. F., Percutaneous Salicylic Acid Intoxication in Psoriasis, Archives of Dermatology, 90, pp. 614–619, 1964.
11.
GaudinO., Amine Salicylate Ointment, U.S. Patent: 2,596,674, May 13, 1952.
